Table 1. Patient's Clinical Antecedents... | American Society of Hematology

Table 1.

Patient's Clinical Antecedents and Laboratory Parameters During the Observation Period

Date		PRP (×10⁻⁹L)	Aggregation^-152 by Ristocetin (0.5 mg/mL)		FVIII (% of normal)	vWF Ag (% of normal)	Ristocetin Cofactor (% of normal)
Date		PRP (×10⁻⁹L)	Amplitude (%)	Velocity (%)	FVIII (% of normal)	vWF Ag (% of normal)	Ristocetin Cofactor (% of normal)
1959	Year of birth
1982	Intrauterine death at 26 wk: multiple placental infarcts
1983	Intrauterine death at 28 wk: multiple placental infarcts
1995	Left temporo-occipital CVA preceded by “flu”
29/3/96	Myocardial infarction, autoimmune hyperthyroidism
22/4/96	Coronarography negative, ANF negative, thrombophilia negative, start aspirin 160 mg/d	239^-150	86	91	115	75	100
26/4/96	Start aspirin 1,000 mg/d	276^-150	58	57
30/4/96		244^-151	59	60
12/6/96	Recurrence of “flu,” ANF positive, corticosteroids added	481	53	47
9/7/96	Corticosteroids reduced	375^-151	47	58		75
27/8/96	Corticosteroids stopped, ticlopidine + aspirin 100 mg	385	46	55
8/10/96		400	32	44	—	50	46
10/12/96		433	55	55	82	62	55
3/6/97		443^-151	57	66	96	41	55

Date		PRP (×10⁻⁹L)	Aggregation^-152 by Ristocetin (0.5 mg/mL)		FVIII (% of normal)	vWF Ag (% of normal)	Ristocetin Cofactor (% of normal)
Date		PRP (×10⁻⁹L)	Amplitude (%)	Velocity (%)	FVIII (% of normal)	vWF Ag (% of normal)	Ristocetin Cofactor (% of normal)
1959	Year of birth
1982	Intrauterine death at 26 wk: multiple placental infarcts
1983	Intrauterine death at 28 wk: multiple placental infarcts
1995	Left temporo-occipital CVA preceded by “flu”
29/3/96	Myocardial infarction, autoimmune hyperthyroidism
22/4/96	Coronarography negative, ANF negative, thrombophilia negative, start aspirin 160 mg/d	239^-150	86	91	115	75	100
26/4/96	Start aspirin 1,000 mg/d	276^-150	58	57
30/4/96		244^-151	59	60
12/6/96	Recurrence of “flu,” ANF positive, corticosteroids added	481	53	47
9/7/96	Corticosteroids reduced	375^-151	47	58		75
27/8/96	Corticosteroids stopped, ticlopidine + aspirin 100 mg	385	46	55
8/10/96		400	32	44	—	50	46
10/12/96		433	55	55	82	62	55
3/6/97		443^-151	57	66	96	41	55

Abbreviations: CVA, cerebrovascular accident; ANF, antinuclear factor.

Blood platelets aggregated spontaneously following stirring of PRP.

No spontaneous platelet aggregation in stirred PRP.

Amplitude and velocity of normal controls <10% each.